SFC Fluidics, Inc. Receives FDA Breakthrough Device Designation
FDA’s BDD program targets novel devices with the potential to provide patients with a more effective treatment for life-threatening or irreversibly debilitating diseases. SFC’s insulin pod promises to substantially...
